Georgia Jury Delivers Near-Record Verdict in Ongoing Weedkiller Litigation Battle
A Georgia jury ordered Monsanto parent company Bayer to pay nearly $2.1 billion in damages to John Barnes, who claimed the popular Roundup weedkiller caused his non-Hodgkin’s lymphoma. The verdict, reached late Friday in a Georgia courtroom, includes $65 million in compensatory damages and $2 billion in punitive damages, marking one of the largest awards in Roundup-related litigation to date. Bayer, which acquired Monsanto in 2018, immediately announced plans to appeal the decision, maintaining that scientific evidence supports Roundup’s safety despite facing over 177,000 similar lawsuits.
5 Key Points
- The $2.1 billion verdict represents the second-largest Roundup-related award, following a $2.25 billion Philadelphia verdict in January 2024.
- Plaintiff John Barnes filed his lawsuit in 2021 seeking damages for non-Hodgkin’s lymphoma he attributes to Roundup exposure.
- Lead attorney Kyle Findley accused Monsanto of “many years of cover-ups” and ignoring scientific studies about Roundup’s toxicity.
- Bayer has set aside $16 billion to settle Roundup cases but continues to dispute claims that the product causes cancer.
- The company claims to have prevailed in 17 of the last 25 related trials and says previous verdicts were reduced by 90% overall.
How Does the Roundup Controversy Affect Agricultural Practices?
Roundup, containing the active ingredient glyphosate, remains one of the world’s most widely used herbicides despite ongoing litigation. The product is designed to work with genetically modified seeds that resist its effects, allowing farmers to produce higher yields while reducing soil tillage. This agricultural approach has transformed modern farming by enabling more efficient weed control across millions of acres worldwide. However, the mounting legal challenges have raised questions about the future availability of the product, with Bayer warning that continued litigation costs could impact access to this widely-used agricultural tool.
What Evidence Links Roundup to Cancer?
The scientific debate surrounding Roundup’s safety continues to divide experts and regulatory bodies. Some studies have associated glyphosate with cancer, particularly non-Hodgkin’s lymphoma, which forms the basis for thousands of lawsuits against Monsanto. However, the U.S. Environmental Protection Agency has maintained that glyphosate is “not likely to be carcinogenic to humans when used as directed.” Lead attorney Kyle Findley claims evidence presented in Barnes’ case revealed “many years of cover-ups” and accused Monsanto of ignoring scientific studies related to Roundup’s toxicity. Findley stated the company “tried to find ways to persuade and distract and deny the connection between this product and non-Hodgkin’s lymphoma,” allegations Monsanto strongly disputes.
Why Has Bayer Continued Fighting These Cases?
Despite the massive financial impact of Roundup litigation, Bayer continues defending the product’s safety rather than removing it from the market. In a statement following Friday’s verdict, Monsanto said the decision “conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide.” The company added that it “continues to stand fully behind the safety” of Roundup products. Bayer’s legal strategy includes appealing unfavorable verdicts while highlighting its claimed success in 17 of the last 25 related trials. The company has also initiated legislative efforts across several U.S. states to protect pesticide manufacturers from failure-to-warn claims when products comply with EPA regulations.
What Does This Verdict Mean for Future Roundup Cases?
Friday’s decision marks the fourth Roundup-related victory for Kyle Findley’s legal team, suggesting a potential pattern in jury responses to evidence presented in these cases. The substantial damages awarded—particularly the $2 billion in punitive damages—indicate jurors found Monsanto’s conduct especially troubling. Findley called the verdict an “important milestone” and “another example of Monsanto’s refusal to accept responsibility for poisoning people with this toxic product.” His law firm has indicated they represent “many more clients who are similarly situated as Mr. Barnes,” signaling continued litigation ahead. However, Bayer notes that previous large verdicts have typically been significantly reduced during the appeals process, claiming a 90% overall reduction in finalized cases.
On this page:
